Kovai, N., et al
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
De Bacco F, Luraghi P, Medico E, Reato G, Girolami F, Perera T, et al
Produkt BPC-157, jako surowiec przeznaczony do bada laboratoryjnych i dalszych procesw wskazuje na duy potencja w przyspieszaniu gojenia urazw ukadu miniowo-szkieletowego, takich jak zamania, zerwania cigien, naderwania wizade i urazy mini
Our Dallas anti-aging and regenerative medicine courses are open to licensed healthcare professionals including physicians (MDs and DOs), nurse practitioners (NPs), physician assistants (PAs), registered nurses (RNs), chiropractors, and naturopathic doctors
The authors noted NNMT overexpression in many human malignancies and described 5-Amino-1MQ as a novel NNMT inhibitor with promising results across obesity and cancer cell research models